Global Protein Stability Analysis Market is estimated to be US$ 2120.66 Million by 2030 with a CAGR
The global protein stability analysis market accounted for US$ 906.65 million in 2020 and is estimated to be US$ 2120.66 million by 2030 and is anticipated to register a CAGR of 8.90%. Proteins are stable, active and efficient when they are folded. During unfavorable conditions, they unfold and hence get inactive and lead to diseases which can’t be cure. Either it could be birth borne diseases or acquire during a life journey. Protein stability analysis helps to determine the stability of proteins in a sample. There are several methods and techniques available to determine protein stability. This analysis is carried out by pharmaceutical & biotechnological industries for drug development and by research and academic institutes. Protein stability can be determined through chromatography, High-Performance Liquid Chromatography, Surface Plasma Resonance, Spectroscopy, Differential Scanning Calorimeter.
The report " Global Protein Stability Analysis Market, By Product (Reagent’s & Assays, Instruments, Consumables, and Accessories & Software) By Technique (Chromatography, Spectroscopy, Surface Plasmon Reasonance, Differential Scanning Calorimetry, and Differential Scanning Fluorimetry), By End User (Pharmaceuticals & Biotechnological Companies, Research & Government Institutes, and Contract Research Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, And Middle East & Africa) - Trends, Analysis And Forecast Till 2030”
In 2019, Thermo Fisher Scientific collaborated with Genovis, for biological drug development to develop advanced workflows for the preparation, characterization, and monitoring of complex biotherapeutics using liquid chromatography-mass spectrometry (LC-MS).
PerkinElmer and therefore the Genome Institute of Singapore opened a joint laboratory in Singapore to develop a state-of-the-art high-throughput screening (HTS) platform. This platform is employed to predict therapeutic sensitivity in next-generation patient-derived tumor models with the goal of bringing precision oncology research results into the clinic.
In 2018, Thermo Fisher Scientific opened its first Bioprocess Design Center in Shanghai, China to attach and collaborate with biologic developers to style bioprocessing solutions.
To know the upcoming trends and insights prevalent in this market, click the link below:
|Related Link: Click here to visit item owner's website (0 hit)|
|Target State: All States|
Target City : All Cities
Last Update : Oct 08, 2021 4:52 AM
Number of Views: 23
|Item Owner : NileshDM|
Contact Phone: 7775049802
|Friendly reminder: Click here to read some tips.|